John Frederick Ek - 20 Mar 2023 Form 3 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role: Chief Financial Officer
Signature: /s/John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol: AKYA
Transactions as of: 20 Mar 2023
Net transactions value: $0
Form type: 3
Filing time: 21 Mar 2023, 17:50:25 UTC
Next filing: 12 Jun 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 Power of Attorney